tiprankstipranks
Trending News
More News >
Theralase Technologies (TSE:TLT)
:TLT
Advertisement

Theralase Technologies (TLT) Stock Statistics & Valuation Metrics

Compare
88 Followers

Total Valuation

Theralase Technologies has a market cap or net worth of C$48.84M. The enterprise value is C$48.66M.
Market CapC$48.84M
Enterprise ValueC$48.66M

Share Statistics

Theralase Technologies has 257,058,320 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding257,058,320
Owned by Insiders
Owned by Institutions

Financial Efficiency

Theralase Technologies’s return on equity (ROE) is -2.06 and return on invested capital (ROIC) is -174.21%.
Return on Equity (ROE)-2.06
Return on Assets (ROA)-1.31
Return on Invested Capital (ROIC)-174.21%
Return on Capital Employed (ROCE)-1.90
Revenue Per Employee73.82K
Profits Per Employee-304.01K
Employee Count14
Asset Turnover0.32
Inventory Turnover0.88

Valuation Ratios

The current PE Ratio of Theralase Technologies is ―. Theralase Technologies’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value30.77
Price to FCF
Price to Operating Cash Flow-14.76
PEG Ratio

Income Statement

In the last 12 months, Theralase Technologies had revenue of 1.03M and earned -4.26M in profits. Earnings per share was -0.02.
Revenue1.03M
Gross Profit554.03K
Operating Income-4.29M
Pretax Income-4.26M
Net Income-4.26M
EBITDA-3.96M
Earnings Per Share (EPS)-0.02

Cash Flow

In the last 12 months, operating cash flow was -3.20M and capital expenditures -91.34K, giving a free cash flow of -3.29M billion.
Operating Cash Flow-3.20M
Free Cash Flow-3.29M
Free Cash Flow per Share-0.01

Dividends & Yields

Theralase Technologies pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.21
52-Week Price Change18.75%
50-Day Moving Average0.21
200-Day Moving Average0.22
Relative Strength Index (RSI)44.21
Average Volume (3m)63.01K

Important Dates

Theralase Technologies upcoming earnings date is Nov 26, 2025, TBA (Confirmed).
Last Earnings DateAug 26, 2025
Next Earnings DateNov 26, 2025
Ex-Dividend Date

Financial Position

Theralase Technologies as a current ratio of 1.61, with Debt / Equity ratio of 19.18%
Current Ratio1.61
Quick Ratio1.05
Debt to Market Cap<0.01
Net Debt to EBITDA>-0.01
Interest Coverage Ratio-177.68

Taxes

In the past 12 months, Theralase Technologies has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Theralase Technologies EV to EBITDA ratio is -16.07, with an EV/FCF ratio of -19.02.
EV to Sales61.58
EV to EBITDA-16.07
EV to Free Cash Flow-19.02
EV to Operating Cash Flow-19.13

Balance Sheet

Theralase Technologies has C$46.33K in cash and marketable securities with C$244.87K in debt, giving a net cash position of C$198.54K billion.
Cash & Marketable SecuritiesC$46.33K
Total DebtC$244.87K
Net CashC$198.54K
Net Cash Per Share<C$0.01
Tangible Book Value Per Share<C$0.01

Margins

Gross margin is 55.80%, with operating margin of -414.96%, and net profit margin of -411.84%.
Gross Margin55.80%
Operating Margin-414.96%
Pretax Margin-411.84%
Net Profit Margin-411.84%
EBITDA Margin-383.18%
EBIT Margin-409.51%

Analyst Forecast

The average price target for Theralase Technologies is C$0.70, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetC$0.70
Price Target Upside268.42% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast16.00%
EPS Growth Forecast9.79%

Scores

Smart Score3
AI Score45
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis